SYNT logo

SyntheticMR AB (publ) Stock Price

NGM:SYNT Community·SEK 1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SYNT Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Price SEK 0

SYNT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

2 Risks
3 Rewards

SyntheticMR AB (publ) Key Details

SEK 94.4m

Revenue

SEK 30.3m

Cost of Revenue

SEK 64.0m

Gross Profit

SEK 54.0m

Other Expenses

SEK 10.0m

Earnings

Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
May 21, 2024
0.24
67.86%
10.61%
0%
View Full Analysis

About SYNT

Founded
2007
Employees
37
CEO
Lena Oredal
WebsiteView website
www.syntheticmr.com

SyntheticMR AB (publ) engages in the development and marketing of imaging solutions for magnetic resonance imaging (MRI) in Sweden, the Middle East, Africa, Europe, North America, South America, and the Asia-Pacific. Its SyMRI delivers various contrast images, biomarker segmentations, and quantitative data with a single MR sequence. The company also offers SyMRI NEURO includes contrast weighted images, as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps that provide objective decision support for the diagnosis and follow-up of patients; SyMRI MSK works on a range of anatomies, and provides quantitative T1, T2, and PD maps, as well as multiple contrast-weighted images; and MAGiC, a customer-specific version of SyMRI IMAGE. In addition, it provides SyMRI Spine and SyMRI Knee that helps in obtaining anatomical information from a single MRI sequence. The company was incorporated in 2007 and is headquartered in Linköping, Sweden.

Recent SYNT News & Updates

Recent updates

No updates